Vijaya Diagnostic Centre Ltd. · NSE:VIJAYA
Vijaya Diagnostic Centre — Q3 FY2024 Earnings Presentation
46 slides from Vijaya Diagnostic Centre's earnings presentation, Feb 5, 2024
Slide 1: Cover letter to stock exchanges
February 05, 2024 To, To, Listing Department The Corporate Relations Department National Stock Exchange Of India Limited, BSE Limited, Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, 25th floor, Dalal Street, Bandra (East), Mumbai- 400 051 Mumbai - 400 001 NSE Symbol. VIJAYA BSE Scri
Slide 2: Q3 & 9M FY24 Earnings Presentation
Q3 & 9M FY24 Earnings Presentation, February 05 2024
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: Disclaimer
Disclaimer Note 1: Disclaimer "With effect from 01 January 2023, the Company has changed its method of depreciation on all Property, Plant and Equipment from Written Down Value (“WDV") method to Straight Line Method (“SLM"), based upon the technical assessment of expected pattern of consumption of t
Slide 5: Q3 FY24 – Performance Snapshot (Y-o-Y & Q-o-Q)
Q3 FY24 – Performance Snapshot (Y-o-Y & Q-o-Q) Q3 FY24 Q3 FY23 YoY % Q2 FY24 QoQ % Revenue ^ 1,327 1,131 17% 1,389 -4% GR % Non Covid 1,325 1,122 18% 1,387 -4% Revenue EBIDTA 523 443 18% 574 -9% -190 EBIDTA Margin 39.4% 39.1% 30 BPs 41.3% BPs Total tests 2.88 2.49 16% 3.03 -5% Total Foofall 0.88 0.7
Slide 6: Q3 FY24 – Performance Snapshot
Q3 FY24 – Performance Snapshot Operational & Financial Highlights – Q3 FY24 2.88 Mn Tests 0.88 Mn INR 1,326.9 Mn INR 1,324.6 Mn +18.1% +16.2% Footfalls Non COVID Non COVID Revenue from operations Non-COVID Revenue Revenue test volume growth (YoY) growth (YoY) 145 Centres INR 258.5 Mn (Includes 18 ce
Slide 7: 9M FY24 – Performance Snapshot
9M FY24 – Performance Snapshot Operational & Financial Highlights – 9M FY24 8.53 Mn Tests 2.57 Mn INR 3,926.0 Mn INR 3,917.2 Mn +18.5% +17.9% Footfalls Non-COVID Revenue Non COVID Non COVID Revenue from operations Revenue test volume growth (YoY) growth (YoY) 145 Centres INR 853.7 Mn (Includes 18 ce
Slide 8: Management comment
Management comment Commenting on the Q3FY24 results performance, Ms. Suprita Reddy, MD & CEO at Vijaya Diagnostic Centre Ltd. said: “Coming to the close of yet another eventful quarter, I’m glad that we recorded an impressive 18% year-on-year non-COVID revenue growth, testifying the strength of our
Slide 9: Key Financial Highlights – Q3 & 9MFY24
Key Financial Highlights – Q3 & 9MFY24 Revenue from Operations EBITDA & EBITDA Margin (%) 39.1% 41.3% 39.4% 39.3% 40.2% 3,926 3,382 1,578 1,329 1,131 1,389 1,327 443 574 523 Q3 FY23 Q2 FY24 Q3 FY24 9MFY23 9MFY24 Q3 FY23 Q2 FY24 Q3 FY24 9MFY23 9MFY24 18.1% 18.7% Shift YoY (%) 17.3% 16.1% PAT & PAT Ma
Slide 10: Revenue Mix – Q3 & 9MFY24
Revenue Mix – Q3 & 9MFY24 Radiology vs. Pathology Breakdown Non-COVID & COVID Allied Breakdown Radiology Pathology Non Covid Covid 0.8% 0.1% 0.2% 64% 64% 64% 65% 64% 99.2% 99.9% 99.8% 36% 36% 36% 35% 36% Q3 FY23 Q2 FY24 Q3 FY24 9MFY23 9MFY24 Q3 FY23 Q2 FY24 Q3 FY24 Non-COVID YoY (%) 18.1% COVID YoY
Slide 11: Q3 & 9MFY24 - Financial and Operational Discussions (Y-o-Y)
Q3 & 9MFY24 - Financial and Operational Discussions (Y-o-Y) • Revenue from operations increased by 17.3% YoY to Rs. 1,326.9 Mn. Non-Covid revenue witnessed an 18.1% YoY growth o Total revenue from operations and Non-Covid revenue excluding PH increased by 16.2% and 16.9% YoY respectively o Non-Covid
Slide 12: Key Operational Highlights
Key Operational Highlights Tests Performed (# in Million) Footfalls (# in Million) Tests / Footfalls (# in Million) 8.53 2.57 3.32 3.32 7.35 2.37 3.29 3.22 3.10 2.49 3.03 2.88 0.77 0.91 0.88 Q3 FY23 Q2 FY24 Q3 FY24 9MFY23 9MFY24 Q3 FY23 Q2 FY24 Q3 FY24 9MFY23 9MFY24 Q3 FY23 Q2 FY24 Q3 FY24 9MFY23 9M
Slide 13: Consolidated Profit & Loss Account – Q3 & 9MFY24
Consolidated Profit & Loss Account – Q3 & 9MFY24 Particulars Q3 FY24 Q3 FY23 Y-o-Y Q2 FY24 Q-o-Q 9MFY24 9MFY23 Y-o-Y Revenue from operations 1,326.9 1,131.2 17.3% 1,388.6 -4.4% 3,926.0 3,382.3 16.1% Cost of materials consumed 159.9 136.7 17.0% 163.5 -2.2% 466.2 433.5 7.5% Employee benefits expense 2
Slide 14: Delivering Top Class Healthcare – State-of-the-Art Hub at Gulbarga
Q3 FY24 – Branching out into adjacent geographies DELIVERING TOP CLASS HEALTHCARE – STATE- OF-THE-ART HUB AT GULBARGA 13
Slide 15: Q3 FY24 – Branching out into adjacent geographies
Q3 FY24 – Branching out into adjacent geographies Gulbarga Facility Entering Karnataka: Inaugurated a Standalone Hub in Gulbarga – November 2023 • Gathering pace in the direction of expansion to adjacent geographies, we set up a futuristic hub in Gulbarga, Karnataka • The center offers a comprehensi
Slide 16: Beyond Organic for Exponential Reach
BEYOND ORGANIC FOR EXPONENTIAL REACH
Slide 17: About PH
About this company Disclaimer Established in 2001, PH is Pune’s largest B2C focused Integrated Diagnostic Chain. Being in the space for 23 long years, it has emerged as a brand of choice, enjoying the trust and patronage of customers across the region. The founder, Dr. Hemanth Dhoka, a Doctor by pro
Slide 18: Key Highlights
Key Highlights Type of Facility Services Available Count Hubs Sample collection, Ultrasound, X-Ray, 2D Echo, BMD, 3 MRI, CT etc., Spokes Sample collection, Ultrasound, X-Ray, 2D Echo etc., 3 Collection Centres (Company run) Sample collection only 12 Collection Centres (Franchisee) Sample collection
Slide 19: High Quality Infrastructure
High Quality Infrastructure 18
Slide 20: Superior Facilities
ge. Superior Facilities VIJAYA ne; DIAGNOSTIC [WisavA] CENTRE The Pioneers in Diagnostic Medicare... |
Slide 21: State-of-the-art Medical Equipment
State-of-the-art Medical Equipment 20
Slide 22: Strategic Expansion
VIJAYA DIAGNOSTIC CENTRE Strategic Expansion
Slide 23: Expanding Strategically in alignment with our vision
Expanding Strategically in alignment with our vision Inorganic Expansion Strategy • Successfully acquired PH, Pune's largest B2C integrated diagnostic chain, expanding our reach. East India Strategy • This strategic acquisition seamlessly aligns with our commitment to providing top-notch • With grow
Slide 24: Company Overview
VIJAYA DIAGNOSTIC CENTRE Company Overview
Slide 25: Vijaya at a Glance
Vijaya at a Glance Vijaya Diagnostic Centre Limited is the largest integrated diagnostic chain in South India with 145 state-of-the-art centres spread across 23 cities 40+ 145 Mission Years of Experience Centres Quality Experience in delivering Quality Our Mission is to make the patient’s medical Di
Slide 26: Our Journey
Our Journey Awarded one of the Best Healthcare Brands 2022 by The Economic Times Awarded Brand of the year One of the earliest in diagnostic services by The Won the Healthcare Leadership Acquired 100% private diagnostic Vijaya Diagnostic Centre Recognized as one of the CEO Magazine and Awards 2022 s
Slide 27: At the Forefront of Introducing New Technologies
At the Forefront of Introducing New Technologies Ultrasound & Nuclear Medicine Fourth Generation 1981 Echocardiography 1986 1993 CT Scan 1994 Mammography facility Hawkeye Gamma Automated Microbiology Real Time RT-PCR Assays 2006 2003 Culture 2000 1999 Bone Densitometry Camera with SPECT & Flow Cytom
Slide 28: Our Pillars of Strength
Our Pillars of Strength 1 One of the leading players in India’s high growth diagnostics market 2 Integrated diagnostics provider offering one-stop solution 3 High brand recall driving customer stickiness 4 Robust technical capabilities and state-of-the-art technology 5 Experienced Board and strong m
Slide 29: One-Stop Solutions for Pathology & Radiology
…offering One-Stop Solutions for Pathology & Radiology Complete Range of Diagnostic Services under One Roof Comprehensive and high quality integrated diagnostic services through our operational network 28
Slide 30: Robust Technical Capabilities with State-of-the-art IT Infrastructure
Robust Technical Capabilities with State-of-the-art IT Infrastructure 30 8 Advanced Software to Manage Clinical Data CT Machines PET CT / Gamma machines 29 250+ MRI Machines Fully Integrated Radiology Radiologists, Lab Doctors & Advance Laboratory Information Systems (RIS) and Physicians Information
Slide 31: Awards & Achievements
Awards & Achievements Our consultant radiologist, Dr. Varsha Joshi, has Vijaya Diagnostic Centre was awarded made significant contributions as an Associate Vijaya Diagnostic Centre has been Editor to the recently published 8th Edition of for excellence in comprehensive recognized for service excelle
Slide 32: Doctors connect program
Doctors connect program Radiology webinar on "Clinilcoradiological Vijaya Diagnostic Centre has organized a Evaluation of Endometriosis" on 20th December Laboratory webinar on Basic Dermatopathology” continuing medical education (CME) on 2023 on 28th December 2023 Radiology in Hyderabad on 7th Oct 2
Slide 33: Doctors connect program
Doctors connect program Vijaya Diagnostic Centre has organized Laboratory webinar on "Anti-globulin Laboratory webinar on "Screening a continuing medical education (CME) (Coombs) Test” on 14th Dec 2023 Markers in First Trimester” on 16th on Radiology in Hyderabad on 22nd Dec (Thursday) November 2023
Slide 34: Experienced Board of Directors
Experienced Board of Directors Dr. S Surendranath Reddy – Founder and Executive Chairman Dr. D Nageshwar Reddy - Non-executive, Independent Director ▪ Founder of Vijaya with 40+ years of experience in building Vijaya as South India’s largest integrated diagnostic chain ▪ Chairman of Asian Institute
Slide 35: Strong Management Team
Strong Management Team Dr. S. Surendranath Reddy Ms. Suprita Reddy Mr. Sunil Chandra Kondapally Mr. Narasimha Raju K.A Founder and Executive Managing Director and Chief Executive Director Chief Financial Officer Chairman Executive Officer Mr. Sheshadri Vasan Mr. Sivaramaraju Vegesna Mr. Hansraj Sing
Slide 36: Awards & Accolades
Awards & Accolades Excellence In Comprehensive Excellence In Comprehensive Excellence In Comprehensive As one of the ‘Most Preferred Most Trusted Brand of the Best Healthcare Brands Diagnostic Care Diagnostic Care Diagnostic Care Workplace 2022’ Year 2023 Times Health 2023 2023 2023 2022 - 23 2023 E
Slide 37: Shareholding Pattern as of 31st December 2023
Shareholding Pattern as of 31st December 2023 Shareholding Pattern – As of 31st December, 2023 Retail & Others Total 5% Marquee Institutional Investors Holding % Wasatch Advisors 9.7% Nippon India 6.2% Aberdeen Standard Investments 5.3% Institutional Holding Promoter & ICICI Mutual Fund 3.4% 40% Pro
Slide 38: Financial & Operational Highlights
Financial & Operational Highlights
Slide 39: Robust Operational Metrics
Robust Operational Metrics Diagnostic Centre (Nos) Footfalls (Mn) Tests Performed (Mn) 121 3.62 3.18 10.05 9.32 95 2.79 2.63 7.91 80 2.38 6.99 7.09 73 61 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 Test per Footfall (Nos) Revenue per Test (INR) Revenue per Footfall (IN
Slide 40: Consistent Financial Performance
Consistent Financial Performance Revenue EBIDTA PAT CAGR:12% CAGR:14% CAGR:17% 4,624 4,592 3,767 2,037 3,388 1,660 1,820 1,097 2,926 1,326 845 846 1,081 625 459 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 EBIDTA Margin (%) PAT Margin (%) 260 bps 270 bps 44.1% 44.1% 22.
Slide 41: Sustainable Cash Generation & Increasing Return Ratios
Sustainable Cash Generation & Increasing Return Ratios Cash & Cash Equivalents CFO / EBIDTA (%) (INR Mn) 2,466 2,554 90% 2,277 1,729 84% 1,215 80% 78% 77% FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 RoCE Pre-Cash (%) RoE 1 (%) 22% 23% 23% 23% 43% 38% 33% 16% 30% 25% FY19 FY20 FY21 FY22 FY23 FY
Slide 42: Annexure
VIJAYA DIAGNOSTIC CENTRE Annexure
Slide 43: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account Particulars FY23 FY22 FY21 FY20 FY19 Revenue from operations 4,592 4,624 3,767 3,388 2,926 Cost of materials consumed 589 715 571 439 405 Employee benefits expense 785 707 574 624 539 Other expenses 1,398 1,165 962 999 901 EBITDA 1,820 2,037 1,660 1,326 1,081 EBITD
Slide 44: Consolidated Balance Sheet
Consolidated Balance Sheet Assets Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 EQUITY AND LIABILITIES Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 NON-CURRENT ASSETS 5,777 4,436 3,022 2,959 2,689 EQUITY 5,466 4,695 3,592 2,741 2,069 Property, plant and equipment 2,940 1,966 1,358 1,398 1,437 Equity share capital 102 10
Slide 45: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Cash Flow from Operating Activities Profit before Tax 1,135 1,474 1,121 834 653 Adjustment for Non-Operating Items 683 572 534 492 431 Operating Profit before Working Capital Changes 1,818 2,046 1,655 1,326 1,084 Changes
Slide 46: Thank You
Thank You For further information please contact: Mr. Siva Rama Raju Head – Strategy & Investor Relations +91 99485 95555 sivaramaraju.v@vijayadiagnostic.in ir@vijayadiagnostic.in www.vijayadiagnostic.com Corporate Office : #6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082,
Vijaya Diagnostic Centre — Q3 FY2024 Earnings Presentation on 6ix